» Articles » PMID: 23523521

Risk Factors and Mortality of Patients with Nosocomial Carbapenem-resistant Acinetobacter Baumannii Pneumonia

Overview
Date 2013 Mar 26
PMID 23523521
Citations 34
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Acinetobacter baumannii is characterized by strictly aerobic, gram-negative, nonmotile, nonlactose-fermenting, oxidase-negative, catalase-positive coccobacilli, and the combination of its environmental resilience and its rapid development of resistance to multiple classes of antimicrobials renders it a successful nosocomial pathogen.

Objectives: The aim of this study was to identify specific risk factors and outcome of nosocomial pneumonia because of carbapenem-resistant Acinetobacter baumannii (CRAB).

Methods: The retrospective study, set in a 1,500-bed referral and tertiary care hospital, was conducted to analyze the clinical and microbiologic data of patients with nosocomial pneumonia because of Acinetobacter baumannii (A baumannii) from January 2006 to December 2011. Comparisons were made between patients with CRAB pneumonia and patients with carbapenem-susceptible A baumannii (CSAB) pneumonia. Only the first isolation of A baumannii was considered.

Results: A total of 145 patients with CSAB pneumonia and 97 patients with CRAB pneumonia was included. Among these patients, the independent risk factors for acquiring CRAB pneumonia were Acute Physiology and Chronic Health Evaluation II (APACHE II) score (>20) at admission, systemic illnesses (chronic respiratory disease and cerebrovascular accident), presence of excess noninvasive or invasive devices (mechanical ventilation), and ever used antibiotics within 28 days (carbapenem and cefepime). The patients with CRAB pneumonia had higher mortality rate than CSAB pneumonia. Multivariate analysis showed that, among patients with A baumannii pneumonia, APACHE II score (>20) at pneumonia onset, infections with other microorganisms, and inappropriate therapy were independently associated with 28-day mortality.

Conclusion: Patients with CRAB pneumonia have a higher mortality rate than those with CSAB pneumonia. The nosocomial occurrence of CRAB pneumonia is strongly related to systemic illnesses, APACHE II score, mechanical ventilation, and ever used antibiotics within 28 days.

Citing Articles

Clinical and metagenomic predicted antimicrobial resistance in pediatric critically ill patients with infectious diseases in a single center of Zhejiang.

Zhang N, Zhang X, Guo Y, Zheng Y, Gai W, Yang Z Ann Clin Microbiol Antimicrob. 2024; 23(1):107.

PMID: 39707302 PMC: 11662477. DOI: 10.1186/s12941-024-00767-3.


Prevalence, Risk Factors, and Outcome of Carbapenem-resistant Infections in a Community Hospital in Madinah, Saudi Arabia.

Gaifer Z, Fallatah R, Alanazi A, Alfagi R, Alharbi L, Osman H Saudi J Med Med Sci. 2024; 12(4):306-313.

PMID: 39539790 PMC: 11556508. DOI: 10.4103/sjmms.sjmms_582_23.


Anti-Acinetobacter Baumannii single-chain variable fragments provide therapeutic efficacy in an immunocompromised mouse pneumonia model.

Basardeh E, Piri-Gavgani S, Moradi H, Azizi M, Mirzabeigi P, Nazari F BMC Microbiol. 2024; 24(1):55.

PMID: 38341536 PMC: 10858608. DOI: 10.1186/s12866-023-03080-9.


Association of biofilm formation, antimicrobial resistance, clinical characteristics, and clinical outcomes among Acinetobacter baumannii isolates from patients with ventilator-associated pneumonia.

Chukamnerd A, Saipetch N, Singkhamanan K, Ingviya N, Assanangkornchai N, Surachat K Clin Respir J. 2024; 18(1):e13732.

PMID: 38286744 PMC: 10784708. DOI: 10.1111/crj.13732.


Molecular Typing of Multidrug-Resistant Acinetobacter baumannii Isolates from Clinical Specimens by ERIC-PCR and MLVA.

Osanloo L, Zeighami H, Haghi F, Shapouri R, Shokri R Curr Microbiol. 2023; 80(11):355.

PMID: 37752362 DOI: 10.1007/s00284-023-03459-x.